Covid, primo studio Iss sui bambini italiani: il vaccino protegge molto meno di quanto si pensasse
Uscito su Lancet, è il primo su numeri altissimi (770.000 bambini tra 5 e 11 anni). Protezione del 29,4% sull’infezione e del 41,1% contro la malattia grave. Quali sono le ragioni di cifre così modeste? Tentiamo qualche risposta
Questo sito fa uso di cookie per migliorare l’esperienza di navigazione degli utenti e per raccogliere informazioni sull’utilizzo del sito stesso. Può conoscere i dettagli consultando la nostra privacy policy. Impostazione CookieACCETTA
Privacy & Cookie
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
